ABSTRACT:
Thiazolo-Triazole is a fused ring heterocyclic system consisting of three nitrogen atoms and one Sulphur atom shows wide range of biological activities. Cancer is the second leading cause of death worldwide. In past few decades, there has been a crucial necessity for the design and development of innovative anticancer drugs that can diminish the serious health problems and unwanted side effects associated with presently used anticancer drugs. Many anticancer drugs are commercially accessible, but nonexistence of selectivity, target specificity, cytotoxicity, and development of resistance lead to serious side effects. Several experiments have been going on to develop compounds with negligible or no side effects. The thiazole and triazole heterocyclic are well-recognized to possess abundant pharmacological activities, including predominantly anticancer, as revealed by various investigations on anticancer compounds and the latest research findings pointed out that to study the anticancer potential of thiazolo-triazole compounds in single scaffold.
Cite this article:
Kale Jyoti D., Pravin B. Akolkar. Review on Thiazolo-Triazole as a Promising Anticancer agent. Asian Journal of Research in Chemistry. 2024; 17(3):169-3. doi: 10.52711/0974-4150.2024.00031
Cite(Electronic):
Kale Jyoti D., Pravin B. Akolkar. Review on Thiazolo-Triazole as a Promising Anticancer agent. Asian Journal of Research in Chemistry. 2024; 17(3):169-3. doi: 10.52711/0974-4150.2024.00031 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2024-17-3-8
REFERENCES:
1. Abdulrasool M .M and Jawad AH. Synthesis, characterization and evaluation of biological activity of new heterocyclic compounds containing 1,2,4-triazoleand 1,3,4-thiadiazole rings. Int. J. App. Sci. Tech. 2012; 2(10):155-164.
2. Nachiket S Dighe, Shashikant R Pattan, Hemlata V Shinde, Deepak S Musmade, Prerana A Chavan and Pratik Patel. Thiazolo-Triazole a nucleus possessing range of pharmacological Activities. Der Pharmacia Lettre. 2011; 2(2): 35-40.
3. Jassim WK, Fayad AA and Jassim IK. Synthesis and characterization of some substituted heterocyclic compounds and evaluation of biological activity. Kerbala J. Pharm. Sci., (2011); 2: 228-240.
4. Parminder Kaur. A review on methods of synthesis of 1,2,4-Triazole derivatives. Int. Res. J. Pharm. 2018; 9(7): 1-35.
5. Shalini, K.; Kumar, N.; Drabu, S.; Sharma, P.K. Advances in synthetic approach to and antifungal activity of Triazoles. Beilstein J. Org. Chem. 2011; 7: 668-677.
6. Vinayak M Gaware, Nachiket S Dighe, Shashikant R Pattan, Hemlata V Shinde. Thiazolo-Triazole a nucleus possessing range of pharmacological activities. A review. Der Pharmacia Lettre. 2010; 2(2): 35-40.
7. Manclus, J.J.; Moreno, M.J.; Plana, E.; Montoya, A. Development of monoclonal immunoassays for the determination of triazole fungicides in fruit juices. J. Agric. Food Chem. 2008; 56: 8793-8800.
8. Parminder Kaur. A review on methods of synthesis of 1,2,4-Triazole derivatives. Int. Res. J. Pharm. 2018; 9(7): 1-35.
9. Marius Mioc, Sorin Avram et. Al. Design, Synthesis and Biological Activity Evaluation of S-Substituted 1H-5-Mercapto-1,2,4-Triazole Derivatives as Anti proliferative Agents in Colorectal Cancer. 2018.
10. Ing. Bercean Vasile Ing. Şişu Eugen, et. al, Simplified method for obtaining 3-aryl-5-mercapto-1,2,4-triazoles. 2003; 54: 368-369.
11. Xavier Collin, Armelle Sauleau et. al, 1,2,4-Triazolo Mercapto and Aminonitriles as Potent Antifungal Agents. Bioorganic & Medicinal Chemistry Letters. 2003;13: 2601–2605.
12. Md Arif Naseer, Asif Husain. Studies on Chromene based 2, 6-disubstituted-Thiazolo [3,2-B] [1,2,4] Triazole derivatives: Synthesis and Biological Evaluation. Journal of Drug Delivery & Therapeutics. 2019; 9(3-s): 236-242.
13. Lesyk, R.; Vladzimirska, O.; Holota, S.; Zaprutko, L.; Gzella, A. New 5-substituted thiazolo[3,2-b] [1,2,4] triazol-6-ones: Synthesis and anticancer evaluation. Eur. J. Med. Chem. 2007; 42: 641–648.
14. Jean-François Riou, Jean-Pierre Hénichart. Bioorganic and Medicinal Chemistry Letters. 2009; 19: 3434–3438.
15. Holota, S.; Komykhov, S.; Sysak, S.; Gzella, A.; Cherkas, A.; Lesyk, R. Synthesis, Characterization and In Vitro Evaluation of Novel 5-Ene-thiazolo[3,2-b] [1,2,4]triazole- 6(5H)-ones as Possible Anticancer Agents. Molecules. 2021; 26: 1162.
16. Jamal El Bakali; Frédérique Klupsch; Aurore Guédin. 2,6-Diphenylthiazolo[3,2b] [1,2,4] triazoles as telomeric G-quadruplex stabilizers. Bioorg. Med. Chem. Lett. 2009; 19: 3434–3438.
17. A.H. Abdelazeem, A.M. Alqahtani, H.H. Arab, Ahmed M. Gouda, Asmaa G. Safi El-Din. Novel benzo [4,5] thiazolo [2,3- C] [1,2,4] triazoles: Design, synthesis, anticancer evaluation, kinase profiling and molecular docking study. Journal of Molecular Structure. 2021; 1246: 131138.
18. S.A.F. Rostom, M.H. Badr, H.A. Abd El Razik, H.M.A. Ashour, Structure based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/Bphosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies. European Journal of Medicinal Chemistry. 2017. doi: 10.1016/j.ejmech.2017.07.053.
19. A.H. Abdelazeem, Alaa M. Alqahtani, Hany A. Omar. Synthesis, biological evaluation and kinase profiling of novel S-benzo[4,5] thiazolo[2,3-c][1,2,4]triazole derivatives as cytotoxic agents with apoptosis-inducing activity. Journal of Molecular Structure. 2020; 1219: 128567.